Viewing Study NCT06099769

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-01-04 @ 7:21 AM
Study NCT ID: NCT06099769
Status: RECRUITING
Last Update Posted: 2025-10-08
First Post: 2023-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Enzalutamide View
None Mifepristone View
None Carboplatin View
None Paclitaxel View
None Capecitabine View
None Eribulin View
None Triple-negative View
None Androgen receptor positive View
None 22-334 View